Genetic studies in humans harboring an inactivating mutation (PAF-AHG994 →  T mutation) indicate that loss of PAF-AH activity is a risk factor for inflammatory and cardiovascular diseases in Japanese cohorts [14, 24]. Here, PLA2G7 is linked to cardiovascular disorder.